Bortezomib Maintenance in High Risk DLBCL

Clinical trial NCT01965977 · UNKNOWN

Trial details

NCT number: NCT01965977
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2015-04-08
Primary completion: 2018-10-30
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.